Tapewire

Nasdaq · USD

REGN

REGENERON PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
2010
SEC CIK
0000872589
Parsed reports
687

Last 12 months

Inside the activity.

0 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202601
Feb 2026035
Mar 2026013
Apr 202609
May 2026012
Jun 202600
Jul 202601
Aug 202602
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 06, 2023 Filed Feb 8, 2023 21:16 UTC Exercise / conversionCommon Stock 3,613 $482.68 $1,743,922.84
Disclosure

SEC source: 0001883850-23-000046 · edgardoc.xml · nonDerivative · entry 1

GOLDSTEIN JOSEPH L · CIK 0001225474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,860

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 06, 2023 Filed Feb 8, 2023 21:15 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,071 $0.00 Strike: $520.01 $0.00
Disclosure

SEC source: 0001883850-23-000045 · edgardoc.xml · derivative · entry 5

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,070

Underlying: Common Stock · 3,071 shares

Expires 2026-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.

Read SEC document
February 06, 2023 Filed Feb 8, 2023 21:15 UTC SaleCommon Stock 500 $797.00 $398,500.00
Disclosure

SEC source: 0001883850-23-000045 · edgardoc.xml · nonDerivative · entry 3

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 6,162

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 06, 2023 Filed Feb 8, 2023 21:15 UTC SaleCommon Stock 3,071 $798.00 $2,450,658.00
Disclosure

SEC source: 0001883850-23-000045 · edgardoc.xml · nonDerivative · entry 2

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,247

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 06, 2023 Filed Feb 8, 2023 21:15 UTC Exercise / conversionCommon Stock 3,071 $520.01 $1,596,950.71
Disclosure

SEC source: 0001883850-23-000045 · edgardoc.xml · nonDerivative · entry 1

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 06, 2023 Filed Feb 8, 2023 21:15 UTC
YANCOPOULOS GEORGEDirector · President and Chief Scientific
SaleCommon Stock 13,189 $800.08 $10,552,255.12
Disclosure

SEC source: 0001883850-23-000044 · edgardoc.xml · nonDerivative · entry 1

YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust for Chldn.

Disclosed balance after: 200,504

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · price: Represents volume-weighted average price of sales of 13,189 shares of Company stock on February 6, 2023 at prices ranging from $800.00 to $800.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

F3 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:10 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $270.43 $0.00
Disclosure

SEC source: 0001883850-23-000037 · edgardoc.xml · derivative · entry 9

Fenimore Christopher R. · CIK 0001697422 · SVP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2023-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:10 UTC Tax withholdingCommon Stock 3,286 $774.29 $2,544,316.94
Disclosure

SEC source: 0001883850-23-000037 · edgardoc.xml · nonDerivative · entry 2

Fenimore Christopher R. · CIK 0001697422 · SVP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,295

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:10 UTC Exercise / conversionCommon Stock 5,000 $270.43 $1,352,150.00
Disclosure

SEC source: 0001883850-23-000037 · edgardoc.xml · nonDerivative · entry 1

Fenimore Christopher R. · CIK 0001697422 · SVP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,581

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:09 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,021 $0.00 Strike: $380.95 $0.00
Disclosure

SEC source: 0001883850-23-000036 · edgardoc.xml · derivative · entry 3

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,720

Underlying: Common Stock · 1,021 shares

Expires 2028-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:09 UTC SaleCommon Stock 1,021 $779.00 $795,359.00
Disclosure

SEC source: 0001883850-23-000036 · edgardoc.xml · nonDerivative · entry 2

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,247

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:09 UTC Exercise / conversionCommon Stock 1,021 $380.95 $388,949.95
Disclosure

SEC source: 0001883850-23-000036 · edgardoc.xml · nonDerivative · entry 1

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,268

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:09 UTC
Landry Robert EEVP Finance CFO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,000 $0.00 Strike: $381.92 $0.00
Disclosure

SEC source: 0001883850-23-000035 · edgardoc.xml · derivative · entry 19

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800

Underlying: Common Stock · 3,000 shares

Expires 2026-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F9 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:09 UTC
Landry Robert EEVP Finance CFO
Tax withholdingCommon Stock 2,248 $774.29 $1,740,603.92
Disclosure

SEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 3

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,857

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:09 UTC
Landry Robert EEVP Finance CFO
Exercise / conversionCommon Stock 3,000 $381.92 $1,145,760.00
Disclosure

SEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 2

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,105

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:09 UTC
Landry Robert EEVP Finance CFO
SaleCommon Stock 739 $764.50 $564,965.50
Disclosure

SEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 1

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,105

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 2 $762.17 $1,524.34
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 11

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,247

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F12 · price: Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $762.15 to $762.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 3 $761.58 $2,284.74
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 10

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,249

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F11 · price: Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2023 at prices ranging from $761.49 to $761.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 4 $760.40 $3,041.60
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 9

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,252

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F10 · price: Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $760.09 to $760.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 4 $759.65 $3,038.60
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 8

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,256

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F9 · price: Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $759.30 to $759.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 7 $758.58 $5,310.06
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 7

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,260

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F8 · price: Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2023 at prices ranging from $758.29 to $758.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 2 $757.29 $1,514.58
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 6

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,267

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F7 · price: Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $757.02 to $757.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 24 $756.77 $18,162.48
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 5

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,269

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F6 · price: Represents volume-weighted average price of sales of 24 shares of Company stock on February 1, 2023 at prices ranging from $756.18 to $756.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 17 $755.50 $12,843.50
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 4

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,293

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F5 · price: Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $755.11 to $755.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 17 $754.45 $12,825.65
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 3

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,310

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F4 · price: Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $754.08 to $754.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 18 $753.54 $13,563.72
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 2

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,327

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3 · price: Represents volume-weighted average price of sales of 18 shares of Company stock on February 1, 2023 at prices ranging from $753.05 to $753.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:15 UTC SaleCommon Stock 2 $752.11 $1,504.22
Disclosure

SEC source: 0001883850-23-000031 · edgardoc.xml · nonDerivative · entry 1

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,345

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · price: Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $752.02 to $752.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:13 UTC
McCourt MarionEVP Commercial
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,100 $0.00 Strike: $372.46 $0.00
Disclosure

SEC source: 0001883850-23-000029 · edgardoc.xml · derivative · entry 4

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,650

Underlying: Common Stock · 1,100 shares

Expires 2029-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:13 UTC
McCourt MarionEVP Commercial
SaleCommon Stock 1,100 $752.19 $827,409.00
Disclosure

SEC source: 0001883850-23-000029 · edgardoc.xml · nonDerivative · entry 2

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,079

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:13 UTC
McCourt MarionEVP Commercial
Exercise / conversionCommon Stock 1,100 $372.46 $409,706.00
Disclosure

SEC source: 0001883850-23-000029 · edgardoc.xml · nonDerivative · entry 1

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
January 27, 2023 Filed Jan 30, 2023 21:11 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1 $0.00 Strike: $520.01 $0.00
Disclosure

SEC source: 0001883850-23-000027 · edgardoc.xml · derivative · entry 5

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,141

Underlying: Common Stock · 1 shares

Expires 2026-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 21:11 UTC SaleCommon Stock 1 $747.00 $747.00
Disclosure

SEC source: 0001883850-23-000027 · edgardoc.xml · nonDerivative · entry 2

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,247

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
January 27, 2023 Filed Jan 30, 2023 21:11 UTC Exercise / conversionCommon Stock 1 $520.01 $520.01
Disclosure

SEC source: 0001883850-23-000027 · edgardoc.xml · nonDerivative · entry 1

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,248

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
January 06, 2023 Filed Jan 10, 2023 21:03 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,070 $0.00 Strike: $520.01 $0.00
Disclosure

SEC source: 0001883850-23-000025 · edgardoc.xml · derivative · entry 5

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,142

Underlying: Common Stock · 3,070 shares

Expires 2026-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F4 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.

Read SEC document
January 06, 2023 Filed Jan 10, 2023 21:03 UTC SaleCommon Stock 3,070 $747.14 $2,293,719.80
Disclosure

SEC source: 0001883850-23-000025 · edgardoc.xml · nonDerivative · entry 2

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,247

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · price: Represents volume-weighted average price of sales of 3,070 shares of Company stock on January 6, 2023 at prices ranging from $747.00 to $747.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 6, 2023 at each separate price.

Read SEC document
January 06, 2023 Filed Jan 10, 2023 21:03 UTC Exercise / conversionCommon Stock 3,070 $520.01 $1,596,430.70
Disclosure

SEC source: 0001883850-23-000025 · edgardoc.xml · nonDerivative · entry 1

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,317

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
January 04, 2023 Filed Feb 24, 2023 21:07 UTC GiftCommon Stock 291 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000050 · edgardoc.xml · nonDerivative · entry 3

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by CLAT

Disclosed balance after: 125,752

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · derivative · entry 14

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F14 · derivative.exercise_date: On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 13

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,347

F13 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 2 $732.18 $1,464.36
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 12

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,182

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F12 · price: Represents volume-weighted average price of sales of 2 shares of Company stock on January 3, 2023 at prices ranging from $732.00 to $732.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 12 $731.59 $8,779.08
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 11

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,184

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F11 · price: Represents volume-weighted average price of sales of 12 shares of Company stock on January 3, 2023 at prices ranging from $731.03 to $731.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 4 $730.35 $2,921.40
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 10

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,196

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F10 · price: Represents volume-weighted average price of sales of 4 shares of Company stock on January 3, 2023 at prices ranging from $730.17 to $730.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 1 $729.92 $729.92
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 9

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,200

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 11 $728.34 $8,011.74
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 8

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,201

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F9 · price: Represents volume-weighted average price of sales of 11 shares of Company stock on January 3, 2023 at prices ranging from $728.02 to $728.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 13 $727.59 $9,458.67
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 7

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,212

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F8 · price: Represents volume-weighted average price of sales of 13 shares of Company stock on January 3, 2023 at prices ranging from $727.06 to $727.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 10 $726.34 $7,263.40
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 6

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,225

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F7 · price: Represents volume-weighted average price of sales of 10 shares of Company stock on January 3, 2023 at prices ranging from $726.00 to $726.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 9 $725.63 $6,530.67
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 5

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,235

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F6 · price: Represents volume-weighted average price of sales of 9 shares of Company stock on January 3, 2023 at prices ranging from $725.00 to $725.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 9 $724.52 $6,520.68
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 4

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,244

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F5 · price: Represents volume-weighted average price of sales of 9 shares of Company stock on January 3, 2023 at prices ranging from $724.05 to $724.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 10 $723.52 $7,235.20
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 3

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,253

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F4 · price: Represents volume-weighted average price of sales of 10 shares of Company stock on January 3, 2023 at prices ranging from $723.25 to $723.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 5 $722.59 $3,612.95
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 2

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,263

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3 · price: Represents volume-weighted average price of sales of 5 shares of Company stock on January 3, 2023 at prices ranging from $722.01 to $722.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.